Theravance (THRX) Tops Q2 EPS by 1c

Theravance (NASDAQ: THRX) reported Q2 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Theravance (THRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c